Skip to main content
Signal8

Chin Peter Scott

SEC insider (Form 3/4/5 filer). CIK 0002124755. Chief Medical Officer at Denali Therapeutics Inc. (DNLI). 1 reported Form 4/5 transaction since Sep 2024; latest on Sep 4, 2026. Located in SOUTH SAN FRANCISCO, CA.

Companies Chin Peter Scott has filed insider reports for

  • Denali Therapeutics Inc. (DNLI): Officer, Chief Medical Officer
Chin Peter Scott profile photo

Chin Peter Scott

CIK: 0002124755

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Denali Therapeutics Inc. logo
DNLI

Denali Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Denali Therapeutics Inc. logo
    DNLI

    Denali Therapeutics Inc.

    Sep 4, 2026
    Sale
    Direct
    1.7K shares at avg. $22.29$37K

1-1 of 1